Positive (fibroblasts) → poor prognosis (shorter relapse-free survival) in luminal A breast cancerPositive (MICs) → poor prognosis (shorter relapse-free survival) in HER2-positive breast cancer. Here, ERBB2 is linked to breast carcinoma.